These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10892638)

  • 1. American Urological Association issues guidelines on the management of bladder cancer.
    Morey SS
    Am Fam Physician; 2000 Jun; 61(12):3734, 3736. PubMed ID: 10892638
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment and follow-up of superficial bladder cancer].
    Raitanen M
    Duodecim; 2002; 118(9):903-9. PubMed ID: 12238168
    [No Abstract]   [Full Text] [Related]  

  • 3. Are we making significant progress in the diagnosis and management of bladder cancer?
    DeCastro GJ; Steinberg GD
    J Urol; 2010 May; 183(5):1667-8. PubMed ID: 20299061
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony].
    Steinbach F; Schuster F
    Aktuelle Urol; 2005 Aug; 36(4):337-41. PubMed ID: 16110407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating bladder cancer: new methods, new management.
    Moore S; Newton M; Grant EG; Keetch DW
    Am J Nurs; 1993 May; 93(5):32-9. PubMed ID: 8488900
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy?
    Weiss C; Wolze C; Engehausen DG; Ott OJ; Krause FS; Schrott KM; Dunst J; Sauer R; Rödel C
    J Clin Oncol; 2006 May; 24(15):2318-24. PubMed ID: 16710030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of superficial bladder cancer.
    Grossman HB
    Compr Ther; 1995 May; 21(5):245-8. PubMed ID: 7621655
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
    Yumura Y; Oogo Y; Takase K; Hamano A; Yamashita Y; Noguchi S; Satomi Y
    Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Squamous cell carcinoma of the urinary bladder after intravesical bacillus Calmette-Guerin therapy for carcinoma in situ: a case report].
    Uemura M; Nishimura K; Nakagawa M; Kanno N; Miyoshi S; Kawano K; Inoue H
    Hinyokika Kiyo; 2004 Nov; 50(11):809-11. PubMed ID: 15628544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal management of the T1G3 bladder cancer.
    Manoharan M; Soloway MS
    Urol Clin North Am; 2005 May; 32(2):133-45. PubMed ID: 15862611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversial issues and optimal management of stage T1G3 bladder cancer.
    Metwalli AR; Kamat AM
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1283-94. PubMed ID: 16925494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravesical therapy for superficial bladder cancer.
    Malkowicz SB
    Semin Urol Oncol; 2000 Nov; 18(4):280-8. PubMed ID: 11101091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The influence over the long-term prognosis of BCG therapy and the surgical treatment in superficial bladder cancer treatment].
    Higashi S; Matsui Y; Takahashi T; Nishiyama H; Ito N; Yamamoto S; Kamoto T; Ogawa O
    Hinyokika Kiyo; 2005 Aug; 51(8):529-31. PubMed ID: 16164268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bladder cancer.
    Gwynn ES; Clark PE
    Curr Opin Oncol; 2006 May; 18(3):277-83. PubMed ID: 16552241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of superficial bladder cancer.
    Dalbagni G
    Nat Clin Pract Urol; 2007 May; 4(5):254-60. PubMed ID: 17483810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of the first recurrence of T1G3 bladder cancer: does intravesical chemotherapy deserve a chance?
    Witjes JA
    Urol Oncol; 2009; 27(3):322-4. PubMed ID: 19414122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications of intravesical therapy for urothelial cancer of the bladder.
    Koya MP; Simon MA; Soloway MS
    J Urol; 2006 Jun; 175(6):2004-10. PubMed ID: 16697786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The best treatment for high-grade T1 bladder cancer is cystectomy.
    Skinner EC
    Urol Oncol; 2007; 25(6):523-5. PubMed ID: 18047965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.